Publications:

Novel aptamer to von Willebrand factor A1 domain (TAGX-0004) shows total inhibition of thrombus formation superior to ARC1779 and comparable to caplacizumab.

Haematologica

Sakai, Kazuya K; Someya, Tatsuhiko T; Harada, Kaori K; Yagi, Hideo H; Matsui, Taei T; Matsumoto, Masanori M

Publication Date: 2020-11-01

Variant appearance in text: VWF: K1362A

PubMed Link: 33131252

Variant Present in the following documents:

• Main text
• 1052631.pdf

View BVdb publication page

Von Willebrand Disease: From In Vivo to In Vitro Disease Models.

Hemasphere

de Boer, Suzan S; Eikenboom, Jeroen J

Publication Date: 2019-10

Variant appearance in text: VWF: K1362A

PubMed Link: 31942548

Variant Present in the following documents:

• hs9-3-e297.pdf

View BVdb publication page

Von Willebrand Factor Abnormalities Studied in the Mouse Model: What We Learned about VWF Functions.

Mediterranean Journal Of Hematology And Infectious Diseases

Casari, Caterina C; Lenting, Peter J PJ; Christophe, Olivier D OD; Denis, Cécile V CV

Publication Date: 2013

Variant appearance in text: VWF: K1362A

PubMed Link: 23936618

Variant Present in the following documents:

• Main text
• mjhid-5-1-e2013047.pdf

View BVdb publication page